Topiroxostat
Product Specifications
UNSPSC Description
Topiroxostat (FYX-051) is a potent and orally active xanthine oxidoreductase (XOR) inhibitor with an IC50 value of 5.3 nM and a Ki value of 5.7 nM. Topiroxostat exhibits weak CYP3A4-inhibitory activity (18.6%). Topiroxostat has the potential for hyperuricemia treatment[1][2].
Target Antigen
Cytochrome P450; Xanthine Oxidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/Topiroxostat.html
Solubility
DMSO : 23.5 mg/mL (ultrasonic;warming)
Smiles
N#CC1=NC=CC(C2=NNC(C3=CC=NC=C3)=N2)=C1
Molecular Weight
248.24
References & Citations
[1]Sato T, et al. Discovery of 3-(2-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051 - a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia [corrected]. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6225-9.|[2]Matsumoto K, et al. FYX-051: a novel and potent hybrid-type inhibitor of xanthine oxidoreductase. J Pharmacol Exp Ther. 2011 Jan;336(1):95-103.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-14874/Topiroxostat-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-14874/Topiroxostat-SDS-MedChemExpress.pdf
Clinical Information
Launched
CAS Number
577778-58-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
201-12-5655 96 Tests
Human major histocompatibility complex, class II, DP beta 1 (HLA-DPB1) ELISA Kit
Ask
View Details 
